From Sun Pharma to Lupin, pharma stocks rally on quarterly show

Companies put up stellar performance in Indian as well as US markets

Led by Sun Pharma, which gained over 7 per cent, and Lupin, with 4.7 per cent rise, the BSE Pharma sector was among the biggest sectoral gainers.
 
The rally in the sector, which has been reeling under pricing pressure, regulatory issues and muted top line growth, was on account of a better-than-expected March quarter performance.
 
In at least four quarters, a majority of Indian generic pharma majors with a strong presence in the US have posted a sequential improvement in their US business.
 
While Sun Pharma’s March quarter revenues were 11.6 per cent higher than the December